Article
Novel therapeutic targets in salivary duct carcinoma uncovered by comprehensive molecular profiling
14 Oct 2019
Abstract excerpt
Salivary duct carcinoma (SDC) is a rare, aggressive salivary gland malignancy, which often presents at an advanced stage. A proportion of SDC are characterized by HER2 amplification and/or overexpression of androgen receptor (AR), which could be targeted in a subset of patients, but the presence of AR splice variant-7 (AR-V7) in some SDC cases could result in resistance to anti-androgen therapy. We evaluated a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
